NSC |
Compound |
Enrichment |
Correlation |
NSC 720174 |
Null |
0.0420420371076614 |
-0.11644135 |
NSC 722222 |
Null |
0.0420420371076614 |
0.096341247 |
NSC 725191 |
1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol |
0.0420420371076614 |
0.15767194 |
NSC 734977 |
Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate |
0.0420420371076614 |
-0.047287813 |
NSC 735540 |
5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide |
0.0420420371076614 |
0.16858654 |
NSC 737613 |
Null |
0.0420420371076614 |
0.048966276 |
NSC 756166 |
GSK312948A |
0.0420420371076614 |
0.40710704 |
NSC 756251 |
GW559768X |
0.0420420371076614 |
-0.066373329 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0420420371076614 |
0.31720228 |
NSC 79563 |
1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine |
0.0420420371076614 |
0.20366668 |